SEC Form 4 · accession 0001127602-19-009100

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman, President and CEO · Director

Period of report

Feb 27, 2019

Accepted (ET)

Mar 1, 2019 · 11:16 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 27, 2019	S	300	$140.435	D	297,018	D
Common Stock	Feb 27, 2019	S	11	$140.47	D	297,007	D
Common Stock	Feb 27, 2019	S	300	$140.48	D	296,707	D
Common Stock	Feb 27, 2019	S	100	$140.49	D	296,607	D
Common Stock	Feb 27, 2019	S	400	$140.50	D	296,207	D
Common Stock	Feb 27, 2019	S	100	$140.51	D	296,107	D
Common Stock	Feb 27, 2019	S	100	$140.515	D	296,007	D
Common Stock	Feb 27, 2019	S	400	$140.52	D	295,607	D
Common Stock	Feb 27, 2019	S	200	$140.53	D	295,407	D
Common Stock	Feb 27, 2019	S	200	$140.54	D	295,207	D
Common Stock	Feb 27, 2019	S	35	$140.555	D	295,172	D
Common Stock	Feb 27, 2019	S	178	$140.57	D	294,994	D
Common Stock	Feb 27, 2019	S	31	$140.575	D	294,963	D
Common Stock	Feb 27, 2019	S	600	$140.58	D	294,363	D
Common Stock	Feb 27, 2019	S	100	$140.585	D	294,263	D
Common Stock	Feb 27, 2019	S	89	$140.595	D	294,174	D
Common Stock	Feb 27, 2019	S	201	$140.615	D	293,973	D
Common Stock	Feb 27, 2019	S	100	$140.62	D	293,873	D
Common Stock	Feb 27, 2019	S	70	$140.655	D	293,803	D
Common Stock	Feb 27, 2019	S	30	$140.665	D	293,773	D
Common Stock	Feb 27, 2019	S	368	$140.67	D	293,405	D
Common Stock	Feb 27, 2019	S	12	$140.675	D	293,393	D
Common Stock	Feb 27, 2019	S	32	$140.68	D	293,361	D

No Table II lines on this filing.